NYSE:DGX - New York Stock Exchange, Inc. - US74834L1008 - Common Stock - Currency: USD
163.8
-0.67 (-0.41%)
The current stock price of DGX is 163.8 USD. In the past month the price decreased by -1.6%. In the past year, price increased by 27.53%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.07 | 89.50B | ||
CVS | CVS HEALTH CORP | 12.42 | 84.95B | ||
LH | LABCORP HOLDINGS INC | 14.9 | 18.17B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.78 | 13.88B | ||
DVA | DAVITA INC | 14.74 | 11.20B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.15 | 10.60B | ||
CHE | CHEMED CORP | 25.14 | 8.50B | ||
HIMS | HIMS & HERS HEALTH INC | 50.43 | 6.05B | ||
CRVL | CORVEL CORP | 27.53 | 5.91B | ||
GH | GUARDANT HEALTH INC | N/A | 5.55B | ||
OPCH | OPTION CARE HEALTH INC | 26.25 | 5.26B | ||
RDNT | RADNET INC | 79.02 | 3.73B |
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 45,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
QUEST DIAGNOSTICS INC
500 Plaza Drive
Secaucus NEW JERSEY 07094 US
CEO: Stephen H. Rusckowski
Employees: 44000
Company Website: https://www.questdiagnostics.com/
Investor Relations: https://ir.questdiagnostics.com/overview/default.aspx
Phone: 19735202700
The current stock price of DGX is 163.8 USD. The price decreased by -0.41% in the last trading session.
The exchange symbol of QUEST DIAGNOSTICS INC is DGX and it is listed on the New York Stock Exchange, Inc. exchange.
DGX stock is listed on the New York Stock Exchange, Inc. exchange.
23 analysts have analysed DGX and the average price target is 182.14 USD. This implies a price increase of 11.2% is expected in the next year compared to the current price of 163.8. Check the QUEST DIAGNOSTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
QUEST DIAGNOSTICS INC (DGX) has a market capitalization of 18.28B USD. This makes DGX a Large Cap stock.
QUEST DIAGNOSTICS INC (DGX) currently has 44000 employees.
QUEST DIAGNOSTICS INC (DGX) has a support level at 158.57 and a resistance level at 164.37. Check the full technical report for a detailed analysis of DGX support and resistance levels.
The Revenue of QUEST DIAGNOSTICS INC (DGX) is expected to grow by 9.66% in the next year. Check the estimates tab for more information on the DGX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
QUEST DIAGNOSTICS INC (DGX) has a dividend yield of 1.95%. The yearly dividend amount is currently 2.98. Check the full fundamental report for a detailed analysis of DGX dividend history, reliability and sustainability.
QUEST DIAGNOSTICS INC (DGX) will report earnings on 2025-04-22, before the market open.
The PE ratio for QUEST DIAGNOSTICS INC (DGX) is 18.16. This is based on the reported non-GAAP earnings per share of 9.02 and the current share price of 163.8 USD. Check the full fundamental report for a full analysis of the valuation metrics for DGX.
The outstanding short interest for QUEST DIAGNOSTICS INC (DGX) is 2.33% of its float. Check the ownership tab for more information on the DGX short interest.
ChartMill assigns a technical rating of 7 / 10 to DGX. When comparing the yearly performance of all stocks, DGX is one of the better performing stocks in the market, outperforming 90.9% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to DGX. While DGX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months DGX reported a non-GAAP Earnings per Share(EPS) of 9.02. The EPS increased by 3.56% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.77% | ||
ROA | 5.36% | ||
ROE | 12.78% | ||
Debt/Equity | 0.83 |
ChartMill assigns a Buy % Consensus number of 77% to DGX. The Buy consensus is the average rating of analysts ratings from 23 analysts.
For the next year, analysts expect an EPS growth of 8.49% and a revenue growth 9.66% for DGX